Library / Repair / Livagen
Liver bioregulator
Livagen
Bioregulator
ClassKhavinson peptide
Typical routes in papersOral in that tradition
Half-life contextShort
EvidenceRussian bioregulator literature
What it is
Livagen is sold as a liver-directed short peptide in the same bioregulator family as Vilon and Epithalon.
Benefits in plain language
What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.
- Claimed benefit: support liver cells under toxic or aging load.
- This is organ-targeting folklore plus older papers, not a Hep-C drug.
- Useful as a labeled shelf item people will ask about.
If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.
Mechanism of action
Claimed chromatin / expression effects in hepatocytes. Receptor-level Western characterization is limited.
Possible side effects / caveats
Unknowns plus the usual unregulated-product risk.
Protocol ranges
| Source tier | Amount | Frequency / duration | Notes |
|---|---|---|---|
| Cited courses | 1–2 mg class | 10–20 day courses | Tradition |
Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.